Form 4 for UPST Upstart Holdings, Inc.
Accepted 2025-07-07 00:00:00 ET · period of report 2025-07-02 · accession 0001647639-25-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-07 | 2025-07-02 | UPST | Mirgorodskaya Natalia | See Remarks | M - OptEx | $24.15 | +6,533 | 31.2K | +27% | +$157.8K |
| D | 2025-07-07 | 2025-07-02 | UPST | Mirgorodskaya Natalia | See Remarks | S - Sale+OE | $70.06 | -6,533 | 24.6K | -21% | -$457.7K |
| DM | 2025-07-07 | 2025-07-02 | UPST | Mirgorodskaya Natalia | See Remarks | M - OptEx | $24.15 | -6,533 | 0 | -100% | -$157.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-02 | M | A | 5,460 | $25.90 | 30,083 | D | — | — | (F1) The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 25, 2024. (F2) Certain of these securities listed in Column 5 are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. |
| 2 | Common | Common Stock | 2025-07-02 | S | D | 6,533 | $70.06 | 24,623 | D | — | — | (F1) The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 25, 2024. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-07-02 | M | A | 1,073 | $15.23 | 31,156 | D | — | — | (F1) The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 25, 2024. |
| 4 | Derivative | Employee Stock Option (Right to buy) | 2025-07-02 | M | D | 5,460 | $25.90 | 7,677 | D | $25.90 · — to 2032-08-31 | 5,460 Common Stock | (F4) 1/36th of the shares subject to the option shall vest on September 20, 2022 and at the end of each successive one-month period thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| 5 | Derivative | Employee Stock Option (Right to buy) | 2025-07-02 | M | D | 1,073 | $15.23 | 0 | D | $15.23 · — to 2033-03-17 | 1,073 Common Stock | (F5) All of the shares subject to this option are fully vested and exercisable as of the date hereof. |